Civitas Therapeutics + Acorda Therapeutics
Civitas Therapeutics is now part of Acorda Therapeutics, Inc.
Please click “OK” to be directed to Acorda.com for information
about our products and research, including CVT-301, which is
in development as a treatment for Parkinson’s disease.
OK